Journal Article (Review Article)

DKFZ-2025-01016

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Theranostics in Perspective: White Paper.

Stokkel, M. P. M. ; Gotthardt, M. ; Herrmann, K.DKFZ* ; Gnanasegaran, G.

2025
Soc. New York, NY

Abstract: Nuclear medicine has evolved from a diagnostic-oriented speciality toward theranostics. Radionuclide therapy has become a booming business with newer radiopharmaceuticals and indications. Although the specialty of nuclear medicine seems scintillating, several challenges might limit sustained and long-term success. Some of the challenges and issues requiring clarification include radiopharmaceutical cost and supply, cost-benefit analysis, reimbursement, training, workforce, collaboration with the radiopharmaceutical industry, national and international nuclear medicine, and applied specialities. This review discusses these challenges and possible solutions to avoid speed breakers in theranostics.

Keyword(s): challenges ; future ; opportunities ; radionuclide therapy ; theranostics

Note: 66(7), pp. 1007–1011

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2025

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---